-
Sabalenka surges past Townsend to reach US Open quarter-finals
-
Antonelli living 'a dream' after astonishing home win
-
Smiling face of Germany's far-right AfD: Ulrich Siegmund
-
Impressive Daryz keeps Arc double dream alive
-
Lebanon president calls for US help as Israeli strikes kill 7
-
Strasbourg hit Troyes for six as Amo-Ameyaw sparkles
-
Yamal hits double as perfect Barca thrash Valencia
-
German far-right AfD landslide winner in eastern state vote
-
Venice festival turns gaze on war reporters, media industry
-
Carrick defends Man Utd start despite defensive concerns
-
Sensational Antonelli wins Italian GP from back of grid
-
More than 140 killed in latest Yemen clashes: military sources
-
Susan Sarandon says still losing roles over Gaza stance
-
Van Aert claims shortened Vuelta stage 15 win in high heat
-
US envoys hold 'important' talks in first trip to Kyiv
-
Everton shrug off transfer window woes to hold Man Utd
-
Championship leader Antonelli wins Italian Grand Prix
-
'Nothing has changed': FIFA confirms Infantino to run for re-election
-
Vardy signs for Championship strugglers Burnley
-
UN's Nepal chief makes emotional plea for flood-ravaged country
-
FIFA confirms Infantino will run in presidential election
-
Italian GP red-flagged after massive Leclerc crash
-
With joy and grief, Palestinian football marks return
-
US envoys hold talks with Zelensky on first Kyiv visit
-
Iran threatens greater force if US launches more attacks
-
'Truly scared': Blazes outpace firefighters in Indonesian Borneo
-
Vandals uproot Berlin tree commemorating Pride attack victims
-
German director Wenders clarifies views on film and politics
-
Trump envoys arrive in Kyiv for first Ukraine visit
-
Nepali rescuers buoyed by miracle finds but tough conditions persist
-
Indonesia's main airport suspends operations after volcanic eruption
-
At last: Straight sets win over Tabilo puts Zverev in US Open last 16
-
US aircraft carrier departs Thailand after port call
-
Jovic 'loses sanity five times over' to oust friend Eala in US Open epic
-
Haze emergency grips Malaysian Borneo town
-
China's memories of Mao fade to nostalgia 50 years after his death
-
Messi creates both Miami goals in 2-2 draw with Atlanta
-
US envoys discuss with Putin 'substantive' plans for steps to end Ukraine war
-
Rybakina books US Open fourth-round berth, inches closer to No. 1
-
Zheng stuns Keys as US Open upsets dim American hopes
-
Sobering reality: Curbs on alcohol in northeast Syria cause discontent
-
Jovic 'loses sanity five times over' to oust Eala and book Gauff clash
-
Wobbly Osaka 'shocked' to battle past Mertens and reach last 16
-
'Like a jewel': Japan's luxury ice revered by bars worldwide
-
Indian Oscar-nominated filmmaker turns camera on his cancer
-
'The flood is coming': How a Nepal principal saved 900 students
-
Argentina 'let off hook' by Australia as Kiss's winning run ends
-
Kiss's winning run ends as Argentina hold Australia to draw
-
Argentina threatens to sanction oil projects around Falklands
-
Alcaraz excited to face 'dangerous' Paul for US Open quarter-final berth
Cellev8 Nutrition Inc (Formerly Preferred Commerce) Clarifies Business Focus and Highlights Benefits of Superoxide Dismutase Supplements
, formerly known as Preferred Commerce, today issued a statement to clarify its business focus and retract previous announcements made on June 19, 2019, and July 1, 2020, regarding intentions to enter the CBD/Cannabis industry. The company wishes to correct the record and emphasize that while it had signed a letter of intent to explore opportunities in the CBD/Cannabis sector, it never finalized any agreements or engaged in the purchase or sale of CBD or Cannabis products. Preferred Commerce's exploration of this market did not progress beyond the initial intent phase.
Michael Ferraro, CEO of Cellev8 Nutrition Inc, stated, "Our journey led us to discover groundbreaking opportunities in the health supplement business, specifically in the realm of Superoxide Dismutase (SOD) based products. This discovery has shaped our current identity and mission." Cellev8 Nutrition Inc has established itself as a pioneer in SOD-based supplements, becoming the first company to successfully deliver SOD in gummy form on a commercial scale. The company's focus on leveraging the unmatched effects of superoxide dismutase, coupled with its patent-pending delivery mechanisms, has positioned it in a unique category within the wellness industry.
Benefits of Superoxide Dismutase Supplements Superoxide dismutase (SOD) is a powerful antioxidant enzyme that offers several potential health benefits:
1. Antioxidant Effects: SOD helps neutralize free radicals and protect cells from oxidative damage, potentially reducing inflammation and oxidative stress in the body.
2. Anti-Aging Potential: As SOD levels naturally decrease with age, supplementation may help combat age-related oxidative damage and protect skin from UV damage and signs of aging.
3. Health Support: SOD may help reduce inflammation associated with conditions like arthritis, support cardiovascular health, and have neuroprotective effects.
4. Athletic Performance: Some evidence suggests SOD supplements may aid in exercise recovery and reduce muscle damage in athletes.
5. Potential Cancer-Fighting Properties: Preliminary research indicates SOD may help inhibit tumor growth, though more studies are needed.
"We are proud to serve thousands of customers, including over 40 professional and collegiate athletic teams, who benefit from our products for inflammation, recovery, focus, and memory support," Ferraro added. "Our commitment is to expand our line of wellness products, helping people worldwide live happier and healthier lives." The company looks forward to a future dedicated to innovative wellness solutions, leaving behind any previous considerations of entering the CBD/Cannabis market.
About Cellev8 Nutrition Inc: Cellev8 Nutrition Inc, formerly Preferred Commerce, is a leading provider of Superoxide Dismutase (SOD) based supplements. The company is committed to developing cutting-edge wellness products that promote health and vitality.
Forward-Looking Statements: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current expectations, estimates, and projections about Cellev8 Nutrition Inc's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in Cellev8 Nutrition Inc's filings with the Securities and Exchange Commission.
FDA Disclosure: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Contact Information
Michael Ferraro
CEO
[email protected]
561-578-0000
SOURCE: Cellev8 Nutrition Inc.
B.Torres--AT